title: Antiretroviral therapy update from the 48th ICAAC/46th IDSA annual meeting.
authors.affiliation: ViralEd LLC, Stockton, New Jersey, USA.
authors.forename: Brian A
authors.initials: BA
authors.lastname: Boyle
authors.forename: Calvin J
authors.initials: CJ
authors.lastname: Cohen
authors.forename: Edwin
authors.initials: E
authors.lastname: DeJesus
authors.forename: Richard
authors.initials: R
authors.lastname: Elion
authors.forename: Ian
authors.initials: I
authors.lastname: Frank
authors.forename: Graeme J
authors.initials: GJ
authors.lastname: Moyle
authors.forename: Paul
authors.initials: P
authors.lastname: Sax
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects / Q000379:methods / Q000592:standards; D004338:Drug Combinations; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
chemical_list: D019380:Anti-HIV Agents; D004338:Drug Combinations